Jpmorgan Chase & CO Atea Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 409,259 shares of AVIR stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
409,259
Previous 95,244 329.7%
Holding current value
$1.27 Million
Previous $319,000 329.78%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$2.93 - $3.82 $920,063 - $1.2 Million
314,015 Added 329.7%
409,259 $1.37 Million
Q3 2024

Dec 26, 2024
BUY
$3.17 - $4.02 $155,418 - $197,092
49,028 Added 106.08%
95,244 $319,000
Q3 2024

Nov 08, 2024
BUY
$3.17 - $4.02 $155,418 - $197,092
49,028 Added 106.08%
95,244 $319,000
Q2 2024

Dec 26, 2024
SELL
$3.31 - $4.04 $162,282 - $198,073
-49,028 Reduced 51.48%
46,216 $152,000
Q2 2024

Aug 12, 2024
SELL
$3.31 - $4.04 $188,802 - $230,441
-57,040 Reduced 55.24%
46,216 $152,000
Q1 2024

Dec 26, 2024
BUY
$3.09 - $4.56 $24,757 - $36,534
8,012 Added 8.41%
103,256 $417,000
Q1 2024

May 10, 2024
BUY
$3.09 - $4.56 $107,624 - $158,824
34,830 Added 50.9%
103,256 $417,000
Q4 2023

Dec 26, 2024
SELL
$2.8 - $3.35 $75,090 - $89,840
-26,818 Reduced 28.16%
68,426 $208,000
Q4 2023

Feb 12, 2024
BUY
$2.8 - $3.35 $81 - $97
29 Added 0.04%
68,426 $208,000
Q3 2023

Nov 14, 2023
BUY
$3.0 - $3.79 $16,500 - $20,845
5,500 Added 8.74%
68,397 $205,000
Q2 2023

Aug 11, 2023
BUY
$3.21 - $5.06 $2,195 - $3,461
684 Added 1.1%
62,897 $235,000
Q1 2023

May 18, 2023
BUY
$3.0 - $4.97 $175,356 - $290,506
58,452 Added 1554.16%
62,213 $208,000
Q1 2023

May 11, 2023
SELL
$3.0 - $4.97 $618,771 - $1.03 Million
-206,257 Reduced 98.21%
3,761 $12,000
Q4 2022

Feb 13, 2023
BUY
$4.35 - $6.17 $108,636 - $154,089
24,974 Added 13.5%
210,018 $1.01 Million
Q3 2022

Nov 14, 2022
BUY
$5.49 - $8.79 $771,010 - $1.23 Million
140,439 Added 314.85%
185,044 $1.05 Million
Q2 2022

Aug 11, 2022
SELL
$5.33 - $8.18 $932,723 - $1.43 Million
-174,995 Reduced 79.69%
44,605 $317,000
Q1 2022

May 11, 2022
BUY
$5.5 - $9.19 $955,240 - $1.6 Million
173,680 Added 378.22%
219,600 $1.59 Million
Q4 2021

Feb 10, 2022
BUY
$7.67 - $44.59 $15,876 - $92,301
2,070 Added 4.72%
45,920 $411,000
Q3 2021

Nov 12, 2021
BUY
$21.33 - $35.06 $935,320 - $1.54 Million
43,850 New
43,850 $1.54 Million

Others Institutions Holding AVIR

# of Institutions
108
Shares Held
53.9M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $259M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email